SAMYANG BIOPHARMACEUTICALS

SAMYANG BIOPHARMACEUTICALS Company Introduction

Samyang Biopharmaceuticals is a leading pharmaceutical company headquartered in South Korea, deeply committed to improving human health through innovative research, development, and manufacturing of advanced healthcare products. Established as a key division of the larger Samyang Group, the company focuses on therapeutic areas such as oncology, offering a range of anti-cancer drugs. Beyond pharmaceuticals, Samyang Biopharmaceuticals is also a significant player in the medical device sector, producing high-quality surgical sutures and drug-eluting stents. The company emphasizes R&D, striving to develop novel drugs and medical solutions that address unmet medical needs globally. Its operations encompass the entire value chain from discovery to production and commercialization.

Is it a factory or a trading company?

Samyang Biopharmaceuticals is primarily a factory (manufacturer).

Here are some of the products manufactured or sold by SAMYANG BIOPHARMACEUTICALS:

* **Biopharmaceuticals:**

* Rigenclav (Hyaluronic Acid Dermal Filler)

* Nextorellis (Paclitaxel Injection - Nanoparticle Formulation)

* Doxille (Doxorubicin Injection - Liposome Formulation)

* GENEXOL-PM (Paclitaxel Injection - Polymeric Micelle Formulation)

* **Chemical pharmaceuticals:**

* Various generic drugs

* **Medical Devices:**

* Facial masks and other cosmetic/dermatological products

Please note that this list may not be exhaustive, and SAMYANG BIOPHARMACEUTICALS' product portfolio may change over time.